K. Hara

Evaluation of a New Blood Coagulation Factor Xa Inhibitor, KFA-1411, as an Anticoagulant in a Cynomolgus Monkey Hemodialysis Model: Parameters Suitable for Monitoring Anticoagulant Activities

M. Akahane, T. Koizumi, S. Akahane, 2003 .

Orally active factor Xa inhibitors: investigation of a novel series of 3-amidinophenylsulfonamide derivatives using an amidoxime prodrug strategy.

K. Yokoyama, Hiroaki Kobayashi, Tomonaga Ozawa, 2008, Bioorganic & medicinal chemistry letters.

Characteristics of the hemostatic action of KFA-1411, an inhibitor of coagulation factor Xa (FXa), in humans and various animals.

A. Matsuzawa, T. Koizumi, A. Matsuzawa, 2003, The Journal of toxicological sciences.

Prophylactic Effects Of Pilocarpine Hydrochloride On Xerostomia Models Induced By X‐Ray Irradiation In Rats

M. Akahane, Y. Komatsu, T. Asari, 2001, Clinical and experimental pharmacology & physiology.

Suppression of myocardial protein degradation by the protease inhibitor bis[ethyl(2R,3R)-3-[(S)-methyl-1-[4-(2,3,4-tri-methoxy-phenyl-methyl) piperazine-1-ylcarbonyl]butyl-carbonyl]oxiran-2-carboxylat e]sulfate under hypoxia.

T. Toyo-Oka, M. Kitahara, T. Masaki, 1986, Arzneimittel-Forschung.

Ca overload and the action of calcium sensitive proteases, phospholipases and prostaglandin E2 in myocardial cell degradation

T. Toyo-Oka, M. Kitahara, T. Masaki, 1985, Basic Research in Cardiology.

Suppressive effects of the anti-allergic drugs, tranilast and azelastine, on the lysophosphatidylserine-dependent activation of rat mast cells.

I. Kudo, H. Komatsu, S. Ikeda, 1994, Biological & pharmaceutical bulletin.